89 related articles for article (PubMed ID: 26995507)
1. tPA promotes cortical neuron survival via mTOR-dependent mechanisms.
Grummisch JA; Jadavji NM; Smith PD
Mol Cell Neurosci; 2016 Jul; 74():25-33. PubMed ID: 26995507
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol down-regulates a glutamate-induced tissue plasminogen activator via Erk and AMPK/mTOR pathways in rat primary cortical neurons.
Cho KS; Lee EJ; Kwon KJ; Gonzales EL; Kim YB; Cheong JH; Bahn GH; Lee J; Han SH; Kim YT; Shin CY
Food Funct; 2014 May; 5(5):951-60. PubMed ID: 24599349
[TBL] [Abstract][Full Text] [Related]
3. Tissue-type plasminogen activator regulates the neuronal uptake of glucose in the ischemic brain.
Wu F; Wu J; Nicholson AD; Echeverry R; Haile WB; Catano M; An J; Lee AK; Duong D; Dammer EB; Seyfried NT; Tong FC; Votaw JR; Medcalf RL; Yepes M
J Neurosci; 2012 Jul; 32(29):9848-58. PubMed ID: 22815500
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of neuroserpin in rat primary cortical cultures after oxygen and glucose deprivation and tPA.
Rodríguez-González R; Agulla J; Pérez-Mato M; Sobrino T; Castillo J
Neurochem Int; 2011 Feb; 58(3):337-43. PubMed ID: 21163314
[TBL] [Abstract][Full Text] [Related]
5. p53 inhibition provides a pivotal protective effect against ischemia-reperfusion injury in vitro via mTOR signaling.
Li X; Gu S; Ling Y; Shen C; Cao X; Xie R
Brain Res; 2015 Apr; 1605():31-8. PubMed ID: 25681550
[TBL] [Abstract][Full Text] [Related]
6. Tissue-type plasminogen activator mediates neuroglial coupling in the central nervous system.
An J; Haile WB; Wu F; Torre E; Yepes M
Neuroscience; 2014 Jan; 257():41-8. PubMed ID: 24200922
[TBL] [Abstract][Full Text] [Related]
7. cPKCγ-Modulated Autophagy in Neurons Alleviates Ischemic Injury in Brain of Mice with Ischemic Stroke Through Akt-mTOR Pathway.
Wei H; Li Y; Han S; Liu S; Zhang N; Zhao L; Li S; Li J
Transl Stroke Res; 2016 Dec; 7(6):497-511. PubMed ID: 27510769
[TBL] [Abstract][Full Text] [Related]
8. Non-proteolytic neurotrophic effects of tissue plasminogen activator on cultured mouse cerebrocortical neurons.
Lee HY; Hwang IY; Im H; Koh JY; Kim YH
J Neurochem; 2007 Jun; 101(5):1236-47. PubMed ID: 17498240
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin treatment improves neuron viability in an in vitro model of stroke.
Fletcher L; Evans TM; Watts LT; Jimenez DF; Digicaylioglu M
PLoS One; 2013; 8(7):e68281. PubMed ID: 23861877
[TBL] [Abstract][Full Text] [Related]
10. Tissue-type plasminogen activator induces synaptic vesicle endocytosis in cerebral cortical neurons.
Yepes M; Wu F; Torre E; Cuellar-Giraldo D; Jia D; Cheng L
Neuroscience; 2016 Apr; 319():69-78. PubMed ID: 26820595
[TBL] [Abstract][Full Text] [Related]
11. Tissue-type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF-α.
Haile WB; Wu J; Echeverry R; Wu F; An J; Yepes M
J Cereb Blood Flow Metab; 2012 Jan; 32(1):57-69. PubMed ID: 21792242
[TBL] [Abstract][Full Text] [Related]
12. Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator.
Kim YH; Park JH; Hong SH; Koh JY
Science; 1999 Apr; 284(5414):647-50. PubMed ID: 10213688
[TBL] [Abstract][Full Text] [Related]
13. HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator.
Roussel BD; Mysiorek C; Rouhiainen A; Jullienne A; Parcq J; Hommet Y; Culot M; Berezowski V; Cecchelli R; Rauvala H; Vivien D; Ali C
J Cell Sci; 2011 Jun; 124(Pt 12):2070-6. PubMed ID: 21610098
[TBL] [Abstract][Full Text] [Related]
14. Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase.
Kilic E; Kilic U; Matter CM; Lüscher TF; Bassetti CL; Hermann DM
Stroke; 2005 Feb; 36(2):332-6. PubMed ID: 15625301
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin-mediated protection of insect brain neurons involves JAK and STAT but not PI3K transduction pathways.
Miljus N; Heibeck S; Jarrar M; Micke M; Ostrowski D; Ehrenreich H; Heinrich R
Neuroscience; 2014 Jan; 258():218-27. PubMed ID: 24269933
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke.
Yu S; Liu X; Shen Y; Xu H; Yang Y; Ding F
Neuroscience; 2016 Jul; 327():44-52. PubMed ID: 27060484
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates the expression and the release of tissue plasminogen activator (tPA) in neuronal cells: involvement of tPA in the neuroprotective effect of PACAP.
Raoult E; Roussel BD; Bénard M; Lefebvre T; Ravni A; Ali C; Vivien D; Komuro H; Fournier A; Vaudry H; Vaudry D; Galas L
J Neurochem; 2011 Dec; 119(5):920-31. PubMed ID: 21919910
[TBL] [Abstract][Full Text] [Related]
18. Valproic acid induces astrocyte-dependent neurite outgrowth from cultured rat primary cortical neuron via modulation of tPA/PAI-1 activity.
Cho KS; Kwon KJ; Choi CS; Jeon SJ; Kim KC; Park JH; Ko HM; Lee SH; Cheong JH; Ryu JH; Han SH; Shin CY
Glia; 2013 May; 61(5):694-709. PubMed ID: 23378038
[TBL] [Abstract][Full Text] [Related]
19. Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury.
Reddrop C; Moldrich RX; Beart PM; Farso M; Liberatore GT; Howells DW; Petersen KU; Schleuning WD; Medcalf RL
Stroke; 2005 Jun; 36(6):1241-6. PubMed ID: 15879331
[TBL] [Abstract][Full Text] [Related]
20. Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C.
Liu D; Cheng T; Guo H; Fernández JA; Griffin JH; Song X; Zlokovic BV
Nat Med; 2004 Dec; 10(12):1379-83. PubMed ID: 15516929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
